Latanoprostene Bunod
2 NDCs across 1 manufacturer|0 Generic,2 Brand
▸ More about this market▾ Less
The brand product was first FDA-approved on Nov 2, 2017, and the first generic was approved Apr 29, 2025. FDA's Orange Book lists 2 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $128 million on Latanoprostene Bunod across 292,000 claims for 76,000 beneficiaries.
Latanoprostene Bunod is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $102.25 to $102.29 per ML — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$102.25 – $102.29
per ML
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Bausch & Lomb Incorporated manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing LATANOPROSTENE BUNOD
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
VYZULTA 0.024% OPHTH SOLUTION | $102.2899 per ML | 0.00% |
VYZULTA 0.024% OPHTH SOLUTION | $102.2513 per ML | 0.00% |
Frequently Asked Questions
When did Latanoprostene Bunod become available as a generic?
FDA approved the first generic Latanoprostene Bunod (ANDA) on Apr 29, 2025. The Orange Book currently lists 2 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Latanoprostene Bunod?
In 2024, Medicare Part D spent $128 million on Latanoprostene Bunod across 292,000 claims for 76,000 beneficiaries.
How many Latanoprostene Bunod products are on the market?
The Latanoprostene Bunod drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Latanoprostene Bunod?
NADAC reference prices for Latanoprostene Bunod range from $102.2513 to $102.2899 per ML — a 0% difference between cheapest and most expensive.
Which manufacturers make Latanoprostene Bunod?
1 manufacturer lists Latanoprostene Bunod in NADAC. Ranked by number of NDCs, the largest are Bausch & Lomb Incorporated (2).
How has the price of Latanoprostene Bunod changed recently?
Over the past 7 days, 0 Latanoprostene Bunod NDCs rose and 0 fell, with a market-wide average change of +0.0%.